Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination

Journal article

Open access

Peer reviewed

Jashodeep Datta, Shuwen Xu, Julia H Terhune, Cinthia Rosemblit, Erik Berk, Elizabeth Fitzpatrick and Brian J Czerniecki

Journal for immunotherapy of cancer, Vol.2(Suppl 3), pp.P47-P47

2014-11-06

PMCID: PMC4288652

Abstract

Poster Presentation

url

https://doi.org/10.1186/2051-1426-2-S3-P47View

Published (Version of record) Open

1 Record Views

Title: Novel strategy to identify MHC class II-promiscuous CD4+ peptides from tumor antigens for utilization in vaccination
Creators: Jashodeep Datta - University of Pennsylvania
Shuwen Xu - University of Pennsylvania
Julia H Terhune - University of Pennsylvania
Cinthia Rosemblit - University of Pennsylvania
Erik Berk - University of Pennsylvania
Elizabeth Fitzpatrick - University of Pennsylvania
Brian J Czerniecki - University of Pennsylvania
Publication Details: Journal for immunotherapy of cancer, Vol.2(Suppl 3), pp.P47-P47
Publisher: BioMed Central
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
PMCID: PMC4288652
Record Identifier: 991031785530302976